Chemtron Biotech
Chemtron Biotech is a privately held San Diego-based diagnostics manufacturer founded in 2007 that develops lateral flow rapid tests and provides OEM/ODM development, contract manufacturing, and private-label services to brand owners and distributors in the rapid diagnostics market.
- Company typePrivate
- Founded2007
- HeadquartersSan Diego, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Chemtron Biotech does
Chemtron Biotech is a privately held US diagnostics manufacturer founded in 2007 and headquartered in San Diego, California. Per available firmographic data, the company develops and produces rapid diagnostic tests using lateral flow assay technology and additionally offers OEM/ODM development, contract manufacturing, and private-label services to brand owners and distributors in the diagnostics market.
The company's product and service mix is bifurcated: a captive line of rapid diagnostic tests (the typical use case for lateral flow technology spans pregnancy, infectious disease, drugs-of-abuse, and other point-of-care applications), alongside a B2B contract services arm. The OEM/ODM model positions Chemtron Biotech as an outsourced manufacturing partner rather than solely a branded finished-product seller, which allows the firm to monetize formulation and production capacity across multiple downstream brand owners. No details on specific assays, product SKU counts, regulatory clearances (e.g., FDA 510(k), CLIA waiver, or CE marking), or proprietary technology platforms were disclosed in the input.
Chemtron Biotech operates with 51–100 employees, indicating a small-to-mid-sized specialty manufacturer. The business model is fundamentally industrial: revenue is generated through unit sales of branded tests and per-batch/contract payments for OEM/ODM engagements and private-label fulfillment. Pricing, customer concentration, distribution channels, marketing channels, and partnership data are not disclosed in the available sources (the company website returned only a verification/loading screen rather than substantive content), which constrains deeper visibility into unit economics, customer mix, and growth dynamics.
Chemtron Biotech firmographics
Firmographics- Name
- Chemtron Biotech
- Website
- https://uschemtronbio.com
- Company type
- Private
- Founded year
- 2007
- Headcount range
- 51–100 employees
- Short description
- Chemtron Biotech is a privately held San Diego-based diagnostics manufacturer founded in 2007 that develops lateral flow rapid tests and provides OEM/ODM development, contract manufacturing, and private-label services to brand owners and distributors in the rapid diagnostics market.
- Ownership category
- akta.pro rank
Chemtron Biotech industry classification
Industry- Product category
- In Vitro Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)
Keywords
Where Chemtron Biotech is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Markets served
Chemtron Biotech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Chemtron Biotech product offering
Product offeringCore offering
Chemtron Biotech manufactures rapid diagnostic tests (lateral flow assays) and provides OEM/ODM lateral flow development, manufacturing, and private-label services to brand owners, distributors, and other diagnostic companies. Its offering spans custom assay development through scaled production and white-label packaging of finished rapid tests.
Differentiator
Problem solved
Functional benefit
Products and services
- Rapid Diagnostic Tests Finished lateral flow rapid diagnostic test kits manufactured by Chemtron Biotech and supplied to brand customers, distributors, and private-label clients for clinical and point-of-care use.
- OEM Lateral Flow Development Custom lateral flow assay development service in which Chemtron Biotech designs, optimizes, and validates rapid test assays for OEM clients who then market the finished products under their own brand.
- ODM Lateral Flow Manufacturing Contract manufacturing of lateral flow rapid test products on an ODM basis, enabling clients to outsource large-scale production of rapid diagnostic kits without operating their own facility.
- Private-Label Rapid Test Service White-label/private-label rapid test supply service in which Chemtron Biotech manufactures lateral flow diagnostic kits and supplies them packaged under the client's own brand and labeling for resale.
Companies that use Chemtron Biotech
Customer profileIdeal customer profiles1 record
Chemtron Biotech technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Chemtron Biotech partnerships and signals
Strategic signalRecent moves1 record
Expansion highlights2 records
Chemtron Biotech competitors and assessment
Company assessmentDirect peers
- SD Biosensor: SD Biosensor is a major global rapid diagnostic test manufacturer with strong lateral flow capabilities across infectious disease, clinical chemistry, and OTC tests, directly competing in the OEM/ODM space.
- Abingdon Health: Abingdon Health is a UK-based lateral flow OEM/contract manufacturer offering assay development, manufacturing, and reader services; it competes for the same private-label and OEM customer accounts as Chemtron.
- DCN Diagnostics: DCN Diagnostics is a Carlsbad, CA-based CDMO specializing in lateral flow assay development, manufacturing, and OEM services, making it a close geographic and capability peer to Chemtron Biotech.
- BBI Solutions (Merck KGaA): BBI Solutions is a long-standing lateral flow assay OEM and reagent supplier (now part of Merck KGaA), offering contract development, manufacturing, and private-label services across human and animal diagnostics—the same core service stack as Chemtron.
- Access Bio: Access Bio is a U.S.-headquartered rapid diagnostic test manufacturer with broad lateral flow capabilities across infectious disease, women's health, and OTC applications, providing both branded and OEM products.
- EKF Diagnostics: EKF Diagnostics manufactures and supplies a wide range of rapid diagnostic tests and point-of-care devices, including lateral flow assays, and serves similar OEM/private-label channels as Chemtron.
Emerging players
- Sona Nanotech: Sona Nanotech develops lateral flow assays based on gold nanorod technology and offers development/OEM services, providing a comparable but more R&D-focused lateral flow counterpart to Chemtron's manufacturing model.
Broad incumbents
- Bio-Rad Laboratories: Bio-Rad is a large life-science tools and clinical diagnostics company with a portfolio spanning quality controls, immunoassays, and rapid tests, making it a broader incumbent competing for adjacent OEM and clinical diagnostic customers.
- QuidelOrtho: QuidelOrtho is a large, established diagnostics company with a broad rapid test portfolio (including Sofia lateral flow products); it overlaps with Chemtron's end markets but operates at much greater scale and brand recognition.
Regional players
- Xiamen Biotime Biotechnology: Xiamen Biotime is a China-based manufacturer of in-vitro diagnostic reagents and rapid test kits, including lateral flow products, representing the low-cost Asian OEM segment that competes with Chemtron's U.S.-based offering.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat3 records
Key risks4 records
Key highlights4 records
Customer concentration
Chemtron Biotech social profiles
Digital presenceChemtron Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Chemtron Biotech leadership team
Management profileNumber of profiles
Chemtron Biotech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Chemtron Biotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Chemtron Biotech
What does Chemtron Biotech do?
Chemtron Biotech manufactures rapid diagnostic tests (lateral flow assays) and provides OEM/ODM lateral flow development, manufacturing, and private-label services to brand owners, distributors, and other diagnostic companies. Its offering spans custom assay development through scaled production and white-label packaging of finished rapid tests.
When was Chemtron Biotech founded?
Chemtron Biotech was founded in 2007. It employs 51 to 100 people.
Where is Chemtron Biotech based?
Chemtron Biotech is headquartered in San Diego, United States, in the North America region.
Who are Chemtron Biotech's main competitors?
Direct peers on record are SD Biosensor, Abingdon Health, DCN Diagnostics, BBI Solutions (Merck KGaA), Access Bio and EKF Diagnostics. Sona Nanotech is listed as an emerging player. Broad incumbents are Bio-Rad Laboratories and QuidelOrtho. Xiamen Biotime Biotechnology is listed as a regional player.
Does Chemtron Biotech have an API?
No public API is recorded for Chemtron Biotech.
What industry is Chemtron Biotech in?
Chemtron Biotech's product category is In Vitro Diagnostics. Its primary akta.pro industry code is HLAIALAD, CMC & Pharmaceutical Development (Formulation/Process/Analytical Development). Its NAICS code is 325413 and its SIC code is 2835.